Autor der Publikation

Role of disease risk scores in comparative effectiveness research with emerging therapies.

, , und . Pharmacoepidemiology and drug safety, (Mai 2012)Propensity score; Disease risk score; CER.
DOI: 10.1002/pds.3231

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

 

Weitere Publikationen von Autoren mit dem selben Namen

One-to-many propensity score matching in cohort studies., , , , , und . Pharmacoepidemiology and drug safety, (Mai 2012)Propensity score.Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes., , und . Diabetes, obesity & metabolism, (April 2020)Databases; Diabetis; CER; Publicació; Checklist.Impact of longitudinal data-completeness of electronic health record data on risk score misclassification., , , und . J. Am. Medical Informatics Assoc., 29 (7): 1225-1232 (2022)Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses, , , , , , , , , und 17 andere Autor(en). 329 (16): 1376 (2023)Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information., , , , und . Medical care, 45 (10 Supl 2): S158-65 (Oktober 2007)6354<m:linebreak></m:linebreak>LR: 20091118; GR: R01 023178/PHS HHS/United States; GR: R01 AG023178-03/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Anti-Inflammatory Agents, Non-Steroidal); RF: 46; NIHMS40822; OID: NLM: NIHMS40822; OID: NLM: PMC2265540; ppublish;<m:linebreak></m:linebreak>CER.Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework., , , , , , , , , und 6 andere Autor(en). npj Digit. Medicine, (2021)Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations., , und . Medical care, 45 (10 Supl 2): S44-9 (Oktober 2007)6352<m:linebreak></m:linebreak>GR: AG19463/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Cyclooxygenase 2 Inhibitors); ppublish;<m:linebreak></m:linebreak>CER.Instrumental variable methods in comparative safety and effectiveness research., , und . Pharmacoepidemiology and drug safety, 19 (6): 537-54 (Juni 2010)5676<m:linebreak></m:linebreak>GR: 1 K01 HS018088/HS/AHRQ HHS/United States; GR: 290-2005-0016-I-TO3-WA1/PHS HHS/United States; GR: K25AG027400/AG/NIA NIH HHS/United States; JID: 9208369; NIHMS205457; OID: NLM: NIHMS205457 Available on 06/01/11; OID: NLM: PMC2886161 Available on 06/01/11; ppublish;<m:linebreak></m:linebreak>Variables instrumentals.Plasmode simulation for the evaluation of pharmacoepidemiologic methods in complex healthcare databases., , , und . Comput. Stat. Data Anal., (2014)High-dimensional propensity score adjustment in studies of treatment effects using health care claims data., , , , , und . Epidemiology (Cambridge, Mass.), 20 (4): 512-22 (Juli 2009)5216<m:linebreak></m:linebreak>GR: R01-AG018833/AG/NIA NIH HHS/United States; GR: R01-AG021950/AG/NIA NIH HHS/United States; GR: R01-AG023178/AG/NIA NIH HHS/United States; GR: R01-AG027400/AG/NIA NIH HHS/United States; GR: R01-MH078708/MH/NIMH NIH HHS/United States; JID: 9009644; CIN: Epidemiology. 2009 Jul;20(4):523-4. PMID: 19525688; ppublish;<m:linebreak></m:linebreak>Propensity score.